Skip to main content

Table 2 Clinical process data by study phase - feasibility and audit participants

From: Electronic patient-reported monitoring of symptoms during follow-up of ovarian cancer patients: a feasibility study

 

All participants

Completed 12-month study

Left study

Hospital A participants

Hospital B participants

 

Audit N = 44a

Feasibility N = 23 b

Audit N = 19

Feasibility N = 13

Audit N = 25b

Feasibility N = 10b

Audit N = 16a

Feasibility N = 7b

Audit N = 28

Feasibility N = 16

Total number (mean) of visits

163 (3.7)

28 (1.2)

76 (4.0)

10 (0.8)

87 (3.5)

18 (1.8)

55 (3.4)

10 (1.4)

108 (3.9)

18 (1.1)

Mean number of weeks per visit

9.9

22.5

13.8

23.3

7.0

21.3

11.7

12.3

8.9

26.9

Total number (mean) of phonecalls

75 (1.7)

128 (5.6)

32 (1.7)

78 (6.0)

43 (1.7)

50 (5.0)

11 (0.7)

24 (3.4)

64 (2.3)

104 (6.5)

Mean number of weeks per phonecall

10.6

9.1

13.9

9.9

8.1

8.0

10.7

11.5

10.5

8.0

Total number (mean) of contacts (visits + phonecalls)

238 (5.4)

156 (6.8)

108 (5.7)

88 (6.8)

130 (5.2)

68 (6.8)

66 (4.1)

34 (4.9)

172 (6.1)

122 (7.6)

Mean number of weeks per contact

7.6

7.8

10.8

9.0

5.2

6.2

10.2

9.4

6.1

7.1

  1. a Excluded 1 participant who withdrew on day 16
  2. b Excluded 1 participant who withdrew on day 4